SCHEMBL15910765

SCHEMBL15910765

C=C(C)C(=O)OCCCCCOc1c(OC)cccc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.56
▸ POLB P06746 2/20 0.53
▸ APEX1 P27695 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ TSHR P16473 3/20 0.51
▸ ALDH1A1 P00352 4/20 0.49
▸ LMNA P02545 4/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ MAPK1 P28482 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910892 1.00 SMN1; SMN2 (0.56) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910690 0.99 SMN1; SMN2 (0.57) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910699 0.96 SMN1; SMN2 (0.62) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910991 0.91 SMN1; SMN2 (0.54) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910565 0.87 LMNA (0.60) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910755 0.87 LMNA (0.60) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910793 0.85 LMNA (0.61) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL28401961 0.82 TSHR (0.43) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL28407867 0.82 TSHR (0.43) SMN1; SMN2POLBAPEX1HTTTDP1
SCHEMBL15910691 0.82 POLB (0.56) SMN1; SMN2POLBAPEX1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762506-B1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2022-09-07 — — EP disclosed
US-9708424-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2017-07-18 — — US disclosed
US-20170051093-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2017-02-23 — — US disclosed
US-9512247-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2016-12-06 — — US disclosed
US-20140243444-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORPORATION (JP) 2014-08-28 — — US disclosed
EP-2762506-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION Kaneka Corporation (JP) 2014-08-06 — — EP disclosed
Send feedback